Cargando…
The Impact of Antiviral Treatment of Hepatitis B Virus after Kidney Transplant and the Latest Insights
Background: The current frequency of hepatitis B virus infection in patients with advanced chronic kidney disease (CKD) (including patients on maintenance dialysis and kidney transplant recipients) is low but not negligible worldwide. HBV has a deleterious effect on survival after a kidney transplan...
Autores principales: | Fabrizi, Fabrizio, Donato, Maria Francesca, Tripodi, Federica, Regalia, Anna, Lampertico, Pietro, Castellano, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962423/ https://www.ncbi.nlm.nih.gov/pubmed/36839612 http://dx.doi.org/10.3390/pathogens12020340 |
Ejemplares similares
-
Recent Information on Pan-Genotypic Direct-Acting Antiviral Agents for HCV in Chronic Kidney Disease
por: Fabrizi, Fabrizio, et al.
Publicado: (2022) -
An Updated View on the Antiviral Therapy of Hepatitis C in Chronic Kidney Disease
por: Fabrizi, Fabrizio, et al.
Publicado: (2021) -
Vitamin D Status and SARS-CoV-2 Infection in a Cohort of Kidney Transplanted Patients
por: Regalia, Anna, et al.
Publicado: (2022) -
Hepatitis C Virus, Cryoglobulinemia, and Kidney: Novel Evidence
por: Fabrizi, Fabrizio
Publicado: (2012) -
Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies
por: Degasperi, Elisabetta, et al.
Publicado: (2022)